| Estados Unidos | 2,000 mgreference, not a law · 10% | 1,000 mgreference, not a law · 4% | 3,500 mgreference, not a law · 3% | 2,000 mgreference, not a law · 7%Nota de comparación2,500 mg (de 19 a 50 años) · 2,000 mg (51 años o más) |
| Austria | 500 mgrecommendation · 40% | 24 mgrecommendation · 167% · por encima | —no consta | 800 mgrecommendation · 18% |
| Bélgica | 1,000 mglaw · 20% | 39 mglaw · 103% · por encima | —no consta | 1,600 mglaw · 9% |
| Croacia | 800 mglaw · 25% | 200 mglaw · 20% | 1,000 mglaw · 12% | 1,500 mglaw · 9% |
| Chipre | 2,000 mglaw · 10% | 800 mglaw · 5% | —no consta | 1,500 mglaw · 9% |
| Dinamarca | 1,000 mgrecommendation · 20% | 291 mgrecommendation · 14% | —no consta | 1,327 mgrecommendation · 11% |
| EAEU | 900 mglaw · 22% | 150 mglaw · 27% | 1,000 mglaw · 12% | 2,500 mglaw · 6% |
| Estonia | —no consta | 300 mgrecommendation · 13% | —no consta | 2,500 mgrecommendation · 6% |
| Finlandia | —no consta | 300 mgrecommendation · 13% | —no consta | 2,500 mgrecommendation · 6% |
| Francia | 180 mglaw · 111% · por encima | 30 mglaw · 133% · por encima | —no consta | 800 mglaw · 18% |
| Alemania | 250 mgrecommendation · 80% | 30 mgrecommendation · 133% · por encima | —no consta | 500 mgrecommendation · 28% |
| Irlanda | 2,000 mgrecommendation · 10% | 300 mgrecommendation · 13% | —no consta | 2,500 mgrecommendation · 6% |
| Italia | 1,000 mgrecommendation · 20% | 60 mgrecommendation · 67% | —no consta | 1,200 mgrecommendation · 12% |
| Luxemburgo | 1,000 mglaw · 20% | 18 mglaw · 222% · por encima | —no consta | 1,600 mglaw · 9% |
| Malta | 1,000 mgrecommendation · 20% | 800 IUlaw · not compared | —no consta | 1,500 mgrecommendation · 9% |
| Noruega | 1,000 mglaw · 20% | 250 mglaw · 16% | —no consta | 705 mglaw · 20% |
| Polonia | 1,000 mgrecommendation · 20% | 250 mgrecommendation · 16% | —no consta | 1,500 mgrecommendation · 9% |
| Suiza | 750 mglaw · 27% | 205 mglaw · 20% | 550 mglaw · 22% | 750 mglaw · 19% |